Upcoming Conferences in the Life Sciences Industry
Biotech Showcase™
10 Jan 22 -
19 Jan 22
| San Francisco, CA & Virtually
Biotech Showcase™ is the annual conference for Innovators. If you attend as a general attendee, Biotech Showcase and its family of events will give you the opportunity to re-connect with your peers, in-person or virtually, via seamless one-to-one networking. If you are an Investor, this event gives you the opportunity to find thousands of investment opportunities with participating companies ranging from early, mid to later stage, from Startup, over Biotech and large Pharma.
Contact:
EBDcustomerservice@ebdgroup.com
Representatives from Venture Valuation and Biotechgate will participate in Biotech Showcase™.
Biotechgate Digital Partnering February 2022
07 Feb 22 -
11 Feb 22
| Online
Biotechgate Digital Partnering is a virtual conference designed to support the business development of Biotech, Medtech and Pharma companies. Join five days of digital partnering and establish new global connections thanks to pre-arranged one-on-one Zoom meetings, along with informal networking events and workshops.
Contact:
partnering@biotechgate.com
Representatives from Venture Valuation and Biotechgate will participate in Biotechgate Digital Partnering February 2022.
BIO CEO & Investor Conference
14 Feb 22 -
17 Feb 22
| Online or New York, USA
For more than 20 years, the BIO CEO & Investor Conference has fueled the biotech industry networking with premier investor and banking communities, focused on established and emerging publicly traded and select private biotech companies.
Join us in 2022 - either in person or online - for one of the largest investor conferences focused on established and emerging publicly traded and select private biotech companies, where institutional investors, industry analysts, and senior biotechnology executives have the opportunity to shape the future investment landscape of the biotechnology industry
Representatives from Venture Valuation and Biotechgate will participate in BIO CEO & Investor Conference.
Swiss Nordic Bio 2022
23 Mar 22 -
23 Mar 22
| Zurich, Switzerland
Swiss Nordic Bio in Zurich is a high-level partnering and investor event where Swiss and Nordic biotech startups, pharmaceutical companies and investors meet. Swiss Nordic Bio carries 15 years of tradition, previously Swiss Scandinavian Bio-Business Seminar, and is organised by the Nordic countries in cooperation with Swiss partners. The conference has a broad focus within biotech and pharma (drug development, drug delivery, bio materials, medical device, diagnostics, contract manufacturing, CRO, etc.) and gathers small, early stage companies as well as global, commercial corporations. The conference is open for biotech and pharma companies as well as investors within the life science industry.
Contact:
Ms. Milena Arms
Representatives from Venture Valuation and Biotechgate will participate in Swiss Nordic Bio 2022.
BIO-Europe Spring®
28 Mar 22 -
06 Apr 22
| Basel, Switzerland
BIO-Europe Spring® 2022 will bring together the life science community for global dealmaking in-person and digitally. The event will feature one-to-one meetings, company presentations, informal networking, and pre-event courses. The key theme of the BIO-Europe Spring 2022 program, led by Novartis and Roche, will be Innovation. In addition, the rest of the program will focus on Business Development, Therapeutic Areas, and the Biotech Ecosystem.
The conference will take place in-person in Basel, Switzerland March 28-30, as well as online April 4-6.
Contact:
EBDcustomerservice@ebdgroup.com
Representatives from Venture Valuation and Biotechgate will participate in BIO-Europe Spring®.
BioTrinity 2022
26 Apr 22 -
27 Apr 22
| London, United Kingdom
BioTrinity is an established, must-attend London conference, that catalyses growth and supports in-person re-engagement across the life sciences industry.
The event is attended by an ever-evolving audience of early stage and emerging life sciences R&D Companies, investors, large pharma, and other valued partners throughout the life sciences ecosystem. The conference features a focused, relevant, and stimulating programme, led by great speakers, who bring their knowledge, expertise, and vision to the fore in exciting, high-quality sessions.
Representatives from Venture Valuation and Biotechgate will participate in BioTrinity 2022.
Swiss Biotech Day 2022
02 May 22 -
03 May 22
| Basel, Switzerland
The Swiss biotech industry is not slowed down by the Covid pandemic – this was shown at the live Swiss Biotech Day 2021 after it had to be postponed in 2020. Together with our business associates and investors this networking conference has become a great place for innovation, research and the advancement of biotechnology. As one of the leading biotechnology conferences in Europe, the Swiss Biotech Day 2022 is further developing to a truly global networking day and extending to 1.5 days.
Representatives from Venture Valuation and Biotechgate will participate in Swiss Biotech Day 2022.
ChinaBio® Partnering Forum 2022
10 May 22 -
11 May 22
| Beijing & Online
ChinaBio® Partnering Forum is the largest and most productive China-focused life science partnering event. To be held as a hybrid event, May 10-11, the conference will bring together biotech and pharma leaders from around the world along with hundreds of China-based developers of novel technologies for two days of successful partnering.
Representatives from Venture Valuation and Biotechgate will participate in ChinaBio® Partnering Forum 2022.
BIO International Convention 2022
13 Jun 22 -
16 Jun 22
| San Diego, California, United States
The BIO International Convention attracts 15,000+ biotechnology and pharma leaders who come together for one week of intensive networking to discover new opportunities and promising partnerships. We bring together a wide spectrum of life science and application, including drug discovery, biomanufacturing, genomics, biofuels, nanotechnology, and cell therapy.
Representatives from Venture Valuation and Biotechgate will participate in BIO International Convention 2022.